Cargando…

Biliary Tract Cancer: Current Medical Treatment Strategies

Background: Biliary tract cancers (BTCs) include cholangiocarcinomas and gallbladder cancers usually present at an advanced stage, which are considered resectable in less than 20% of cases and characterised by poor prognosis. Methods: In this review, we discussed the most recent therapeutic options...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oneda, Ester, Abu Hilal, Mohammed, Zaniboni, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281170/ https://www.ncbi.nlm.nih.gov/pubmed/32423017 http://dx.doi.org/10.3390/cancers12051237

Ejemplares similares

Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature
por: Oneda, Ester, et al.
Publicado: (2019)

Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023)

Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022)

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
por: Lo, Justin H., et al.
Publicado: (2023)

Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention
por: Oneda, Ester, et al.
Publicado: (2021)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease
por: Libertini, Michela, et al.
Publicado: (2020)

Biliary tract cancer: current challenges and future prospects
por: Ghidini, Michele, et al.
Publicado: (2018)

Current progress in perioperative chemotherapy for biliary tract cancer
por: Ioka, Tatsuya, et al.
Publicado: (2023)

Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)

Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers
por: Conci, Simone, et al.
Publicado: (2023)

Biliary tract cancers: current knowledge, clinical candidates and future challenges
por: Tariq, Noor-ul-Ain, et al.
Publicado: (2019)

New and emerging treatment options for biliary tract cancer
por: Noel, Marcus S, et al.
Publicado: (2013)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

Current options and future directions of systemic therapy for advanced biliary tract cancer
por: Prete, Maria Giuseppina, et al.
Publicado: (2021)

Innovative Approach for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Pilot Study With the Hilotherm Device, the Poliambulanza Hospital Experience
por: Oneda, Ester, et al.
Publicado: (2020)

Biliary tract large cell neuroendocrine carcinoma: current evidence
por: Raiker, Riva, et al.
Publicado: (2019)

Differential Diagnosis of Small Cell Carcinoma of the Ovary or Ovarian Metastases of Small Cell Carcinoma of the Lung: A Case Report and Review of the Literature
por: Oneda, Ester, et al.
Publicado: (2020)

Diagnosis of Mixed Adenoneuroendocrine Carcinoma (MANEC) after Neoadjuvant Chemotherapy for Pancreatic and Gastric Adenocarcinoma: Two Case Reports and a Review of the Literature
por: Oneda, Ester, et al.
Publicado: (2019)

Essential updates to the surgical treatment of biliary tract cancer
por: Matsukuma, Satoshi, et al.
Publicado: (2019)

Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
por: Turkes, Fiona, et al.
Publicado: (2019)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
por: Mirallas, O., et al.
Publicado: (2022)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Risk and Surveillance of Cancers in Primary Biliary Tract Disease
por: Hrad, Valery, et al.
Publicado: (2016)

Robotic Surgery for Biliary Tract Cancer
por: Kone, Lyonell B., et al.
Publicado: (2022)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments
por: Valery, Marine, et al.
Publicado: (2023)

Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives
por: Imperatori, Marco, et al.
Publicado: (2016)

BILIARY TRACT DISORDERS
Publicado: (1984)

Liver Fluke-Associated Biliary Tract Cancer
por: Prueksapanich, Piyapan, et al.
Publicado: (2018)

How I treat biliary tract cancer
por: Lamarca, A., et al.
Publicado: (2022)

Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)

Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
por: Wu, Chiao-En, et al.
Publicado: (2020)

Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers
por: Zhang, Ruyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ncoga4tqid6spdpdrjv3tsas9h